A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting…

By D. Trenk, Gregg Stone, M. Gawaz, A. Kastrati, D. Angiolillo, U. Müller, G. Richardt, J. Jakubowski, F. Neumann. Journal of the American College of Cardiology, 2012

646 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/634d3010c1a8df681925bd159f03f09f8211f0e1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Bonello
2. U. Tantry
3. M. Price
4. D. Sibbing
5. Deepak L. Bhatt
6. R. Marcucci
7. D. Angiolillo
8. D. Trenk

Citations in the corpus

• Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. (2013, background): “The very low event rates in patients with stable CAD successfully treated with current drug-eluting stent, even among those hyporesponsive to clopidogrel, suggest that this patient population will be challenging for future studies to demonstrate the benefits of PFT-directed therapies (12).”